[EN] SUSTAINED RELEASE CANNABINOID MEDICAMENTS<br/>[FR] MÉDICAMENTS DE CANNABINOÏDE À LIBÉRATION PROLONGÉE
                        
                            
                                申请人:STEADY SLEEP RX CO INC
                            
                            
                                公开号:WO2011063164A2
                            
                            
                                公开(公告)日:2011-05-26
                            
                            The present invention provides a medicament which results in delivery of a therapeutic level of one or more cannabinoids during a clinically relevant therapeutic window. The therapeutic window is a longer window than provided by an immediate release medicament such as Marinol containing an equivalent amount of the cannabinoid. Oral administration of the present compositions provides therapeutic dosing while maintaining safe, side effect sparing, levels of a cannabinoid. The present invention also provides methods of treating cannabinoid-sensitive disorders.